People · Operator
Named in public records as an officer, director or promoter · active 2009–2024 · Pharmaceuticals, Other Technology, Other, Retailing
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Equilibre BioPharmaceuticals Corp. | — | Pharmaceuticals | Series B | $47.7M | $79.7M | 2022 |
| Be Your Best, Inc. | — | Other Technology | Seed | $2.0M | $13.3M | 2023 |
| Colorado Bathhouse LLC | — | Other | Seed | $2.0M | $7.3M | 2024 |
| WW NORTON & Co INC | — | Retailing | Pre-Seed | $1.9M | $7.5M | 2009 |
| Altus Equity Group Inc. | — | Other | Seed | $1.4M | $25.3M | 2019 |
| Dominium Advisors, Inc. | — | Other Technology | Pre-Seed | $470K | $7.8M | 2022 |
Peter Simon at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Peter Simon on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Mark Nelson | 1 | 10 |
| David Friedman | 1 | 9 |
| Joel Marcus | 1 | 9 |
| Stephen King | 1 | 4 |
| Philip Barach | 1 | 3 |
| Steven Gordon | 1 | 3 |
| Forrest Jinks | 1 | 3 |
| MARK WOOD | 1 | 3 |
| STEPHEN DUNN | 1 | 3 |
| Steven N Gordon | 1 | 3 |
| Michael Adler | 1 | 2 |
| David A. Friedman | 1 | 2 |
| Samuel Waksal | 1 | 2 |
| Arash Sotoodehnia | 1 | 1 |
| Julia Reidhead | 1 | 1 |
| William Rusin | 1 | 1 |
| Louise Brockett | 1 | 1 |
| Roby Harrington | 1 | 1 |
| Steven Forman | 1 | 1 |
| Jorie A. Krumpfer | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.